News: Dexa Group

Dexa Group, a pharmaceutical company with a high international standard in Indonesia, has reaffirmed its commitment to exporting its goods to Europe. Dexa Group inked a collaboration agreement with Allgen Pharmaceutical & Generic B.V from the Netherlands and Bioton S.A from Poland through its subsidiary Ferron Par Pharmaceuticals. Allgen Pharmaceutical…

The President of the Republic of Indonesia, Joko Widodo (Jokowi), visited the Dexa Group booth at the 2022 Trade Expo Indonesia (TEI) at ICE BSD City, Tangerang, Mr. Dexa Group Commissioner, Mrs. Gracianti Soetikno-Pandji, welcomed the President. The President was accompanied by the Coordinating Minister for the Economy of the…

Following the 53rd anniversary, Dexa Group and the Indonesian Army Health Center officially opened the renovated inpatient room at the Tk II Hospital, dr. AK Gani, Palembang. Dexa Group's devotion to providing public health services and support for the National Health Insurance (JKN) program can be seen in the refurbishment…

According to the Indonesian Toddler Nutrition Status Survey (SSGBI), the incidence of stunting in Indonesia remains at 24.4%, much behind the 14% objective set by the 2020-2024 National Medium-Term Development Plan (RPJMN). For that purpose, Dexa Group cooperated with the National Population and Family Planning Agency (BKKBN) to host a…

For more than 17 years, STIMUNO, the first phytopharmaca immunomodulator in Indonesia, had been relied on by the Indonesian Family to support the health of their immune systems. For this accomplishment, STIMUNO earned the Top 5 Indonesian Mom's Favorite Brands for Multivitamin Category in the Household & Personal Care (non-food)…

Indonesia's Ministry of Industry accelerates seven industrial sectors, including pharmaceuticals, in implementing the Making Indonesia 4.0 roadmap to make Indonesia the top 10 big countries with the most robust economy globally by 2030. In line with this effort, as Indonesia's leading international pharmaceutical company, Dexa Group has implemented industry 4.0…

Dexa Group, as a national pharmaceutical company, is committed to meeting the quality of Indonesian natural raw materials as the content of Indonesian Indigenous Modern Medicines, beginning with cultivation, harvesting, and post-harvest processes and continuing through the manufacturing process by Good Traditional Medicine Manufacturing standards (CPOTB). This is necessary to…

The government primarily focuses on developing phytopharmaceuticals to create a system of health resilience and domestic pharmaceutical self-reliance. Launching the Phytopharmaca Formulary and promoting its usage in medical institutions are examples of the government's commitment to fostering the use of phytopharmaceuticals. The Director General of Pharmaceuticals and Medical Devices at…

With more than 28000 plant species and 2,848 medicinal plants, Indonesia has the second-highest biodiversity in the world. Its natural resources hold tremendous promise for developing phytopharmaceuticals and herbal medicines, including Indonesia Indigenous Modern Medicine (IIMM). Penny K. Lukito, head of the Food and Drug Supervisory Agency (BPOM), stated that…

Indonesia's 29th National Family Day (Harganas) was celebrated with the theme "Let's Prevent Stunting for Stunting-Free Family". President Joko Widodo (Jokowi) said that the government had appointed the National Population and Family Planning Agency (BKKBN) to reduce the prevalence of stunting to 14% in 2024. Therefore, BKKBN collaborates with several…